
The past week has seen plenty of COVID-19 news continue to roll in: The European Commission has sued AstraZeneca over …

An analysis of over 600,000 people’s vaccine reports has been published in The Lancet Infectious Diseases journal, in the largest …

The FDA has granted priority review for the New Drug Applicaton (NDA) for Calliditas Therapeutics’ Nefecon, for the treatment of …

NICE has announced it will join with nine other organisations to form the GetReal Institute, a not-for-profit multi-stakeholder enterprise, as …

A Public Health England (PHE) study into the Pfizer-BioNTech and Oxford-AstraZeneca vaccines has found that a single dose of either …

Biopharmaceutical company Amryt have appointed Sheila Frame as President for the Americas.

F2G Limited has announced that Francesco Maria Lavino has been appointed Chief Executive Officer and member of the Board of …

Macrogen Europe have announced the appointment of a new CEO, Dr Bongcho Kim, who joins the company after a successful …
Eva Temkin, a former senior FDA official for therapeutic biologics and biosimilars, has joined King & Spalding in Washington, US, …

The pharmaceutical industry has historically been slow to adapt to change, with high regulatory hurdles and widespread scepticism facing new …

Jack Goddard inve

The European Commission (EC) announced yesterday that it was suing AstraZeneca for failing to respect its contract to supply COVID-19 …

NICE has updated its guideline on the diagnosis and management of atrial fibrillation (AF) based on new evidence found since …

Hilco Industrial Acquisitions, an Amsterdam based industrial asset disposition and acquisition company, has acquired all machinery and equipment from the …

STORM Therapeutics have published new data in Nature on targeting RNA modifying enzymes for the development of new anti-cancer therapeutics, …

Phesgo, a treatment for breast cancer, will now be offered to patients at home in the UK for the very …

A real-world evidence study, presented at the International Conference on Osteoporosis, Arthritis and Musculoskeletal Disorders, has shown for the first …

Dermavant Sciences have presented successful data from two Phase III trials for tapinarof, for the treatment of psoriasis in adults, …

The Committee for Medicinal Products for Human Use (CHMP) of the European Medicines Agency (EMA) has adopted a positive opinion …

Sanofi have announced positive topline results from the Phase III MELODY trial into nirsevimab, which demonstrated protection against respiratory syncytial …